|Articles|August 1, 2018
- Pharmaceutical Executive-08-01-2018
- Volume 38
- Issue 8
Pharmaceutical Executive, August 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive August 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 8 years ago
Emerging Biotech: Innovation, Location, and Inspirationalmost 8 years ago
Cross-Border Funding in the Life Sciencesalmost 8 years ago
Face It. You’re Not a Biotech Anymorealmost 8 years ago
The Pulse of Biopharma M&Aalmost 8 years ago
The Big Apple’s Fresh Start in Biotechalmost 8 years ago
‘Emerging’ Product Launch Strategiesalmost 8 years ago
Biotech Investment: Reigning in Spainalmost 8 years ago
Traditional Scientific Search is Brokenalmost 8 years ago
Tough Fight Looms in Preserving R&D Incentivesalmost 8 years ago
From Science to SuccessAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharma Funding Roudup: Kardigan Announces $400 Million Initial IPO, cAMPfield Launches with $180 million Series A
2
FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010
3
Pharmaceutical Executive Daily: FDA Advisory Committee Votes Unanimously in Favor of The Benefit-Risk Profile of Moderna's mRNA-1010
4
Additive Manufacturing's Application in Pharma and Biotech
5